Tibet Weixinkang Medicine Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 465.959 million compared to CNY 547.999 million a year ago. Operating income was CNY 48.876 million compared to CNY 44.187 million a year ago. Net income was CNY 45.192 million compared to CNY 44.397 million a year ago. Basic earnings per share from continuing operations was CNY 0.11 compared to CNY 0.1 a year ago.